Goldenwell Biotech (GWLL) Total Liabilities (2020 - 2025)
Goldenwell Biotech's Total Liabilities history spans 6 years, with the latest figure at $315233.0 for Q3 2025.
- For Q3 2025, Total Liabilities rose 58.67% year-over-year to $315233.0; the TTM value through Sep 2025 reached $315233.0, up 58.67%, while the annual FY2024 figure was $271433.0, 88.71% up from the prior year.
- Total Liabilities reached $315233.0 in Q3 2025 per GWLL's latest filing, down from $338133.0 in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $338133.0 in Q2 2025 to a low of $29126.0 in Q3 2022.
- Average Total Liabilities over 5 years is $144873.7, with a median of $145222.0 recorded in 2024.
- Peak YoY movement for Total Liabilities: plummeted 81.16% in 2022, then soared 282.36% in 2024.
- A 5-year view of Total Liabilities shows it stood at $159266.0 in 2021, then tumbled by 70.63% to $46782.0 in 2022, then skyrocketed by 207.46% to $143837.0 in 2023, then surged by 88.71% to $271433.0 in 2024, then rose by 16.14% to $315233.0 in 2025.
- Per Business Quant, the three most recent readings for GWLL's Total Liabilities are $315233.0 (Q3 2025), $338133.0 (Q2 2025), and $273533.0 (Q1 2025).